EconDefense
ACQ-11 / Intellectual property and technology transfer

Exchange laboratory resources and receive partner funding through CRADAs

Collaborate with nonfederal parties using laboratory staff, facilities, equipment and IP; accept and retain partner funds and negotiate invention rights.

Authority / instrument · ACQ-11

Technology transfer

Intellectual property and technology transfer

Statute & instrument
Authority holder

Federal agency authorizing laboratory directors; military-department Secretaries and Secretary of Defense/DARPA may permit FFRDC directors

What this does not authorize / hard limit

CRADA expressly does not permit providing federal funds to nonfederal collaborator. Use a separately justified grant, contract or OT if paying the partner.

Recorded executor

Laboratory ORTA, counsel and authorized agreement official

Continue to actor →

Recorded executing role; this record-specific route is not an additional institutional office.

Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedPartner funds may be accepted, retained and used for collaboration; lab supplies authorized in-kind resources. Office budget figures are separate institutional context, not an allocation to this instrument.
Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent.
EngagementProcess sourcedTurn a shared laboratory R&D objective into a defined project and negotiated contributions—not a request for federal cash. Program check: 2026-10-04; see each route for intake status.

Public evidence describes the institution and instrument; it is not approval of an individual transaction.

At a glance

Possible toolACQ-11 · Cooperation & exchanges

Authority holder: Federal agency authorizing laboratory directors; military-department Secretaries and Secretary of Defense/DARPA may permit FFRDC directors

Cooperation & exchanges

Mechanism tags describe the source text; they do not expand the authority.

Availability and verification

Express statutory pathway; award-specific appropriations, available balances, delegations, implementation and approvals not independently verified.

Program process and intake

Checked 2026-10-04 · process documented. Program evidence is separate from legal authority, available funds and transaction approval.

Turn a shared laboratory R&D objective into a defined project and negotiated contributions—not a request for federal cash.

Laboratory CRADA — NRL and DAF examples

Who this route serves
Non-federal R&D collaborators; this is not a grant application
Administering office / routing lead
Participating laboratory technology-transfer office; DAF T3 provides ORTA services where no local ORTA exists
Direct implementation

DAF expressly identifies 15 USC 3710a. These are examples of the CRADA instrument, not a single department-wide intake.

What this evidence label means
Process documented; project agreement required

The published process was checked; no award or appointment availability is inferred.

Status reference date: 2026-10-04 · research checked 2026-10-04

DAF CRADA process and February 2026 model · Overview; collaborators; model agreementofficial program guidance · Evidence record

Program eligibility

  • At NRL, propose a defined joint project aligned with the laboratory mission; a broad subject area alone is insufficient.

    NRL CRADA process · CRADA definition and partner contributionsofficial program guidance · Evidence record

Steps and preparation

  • Prepare the joint tasks and each party’s contributions with the laboratory TTO. The DAF page provides a February 2026 model agreement for scoping terms.

    DAF CRADA process and February 2026 model · Overview; collaborators; model agreementofficial program guidance · Evidence record
Funding, limits and authority relationship

Funding and financial terms

  • In-kind collaboration / partner reimbursement · Project-specific agreement

    The lab can contribute people, equipment and facilities, but cannot pay the partner through a CRADA; the partner may contribute funds or resources.

    NRL CRADA process · CRADA definition and partner contributionsofficial program guidance · Evidence record

Exclusions and limits

  • Work performed solely by NRL may require a different reimbursable-services agreement. Commercial rights to resulting inventions require the applicable licensing terms.

    NRL CRADA process · CRADA definition and partner contributionsofficial program guidance · Evidence record

Authority relationship source

DAF CRADA process and February 2026 model · Overview; collaborators; model agreementofficial program guidance · Evidence record

Read the official process →

program information: Information and institutional inquiry, not an award application.

Research scope and sources checked

The first program-depth pass checked the cited program pages, notices and legal framework. Evidence is limited to the named routes and source-access notes; it does not establish every implementation of the statute.

What remains unverified

  • Project acceptance, specific technical counterpart, IP terms and execution authority remain agreement-specific.

A dated source check is not continuing monitoring. Recheck the linked official notice before preparing a submission. Browse program research →

Requirements and limits

Eligibility & prerequisites

  • Specified joint R&D consistent with laboratory mission; agency approval/joint-work-statement rules for contractor-operated labs.
  • Small-business consideration, U.S.-manufacturing preference and foreign reciprocity factors.
  • Federal laboratory technology-transfer responsibilities and ORTA assistance under §3710 support routing; invention information under §205 may be withheld for the reasonable period needed to protect patent rights and under its terms.

Limits & exclusions

  • CRADA expressly does not permit providing federal funds to nonfederal collaborator. Use a separately justified grant, contract or OT if paying the partner.
  • Government retained licenses, confidentiality, conflict-of-interest and exceptional license-intervention provisions apply.
  • Technology-transfer duties and confidentiality provisions are not standalone financial assistance or commercial licensing powers; the award or license still uses its own operative authority.

Funding conditions

  • Partner funds may be accepted, retained and used for collaboration; lab supplies authorized in-kind resources.

Read the funding and execution guide

Who contributes what

Need & planning

  • Laboratory scientific lead and Office of Research and Technology Applications

Resources

  • Laboratory director and sponsoring component budget owner

Approval

  • Laboratory director and agency approver as statute/delegation requires

Execution

  • Laboratory ORTA, counsel and authorized agreement official

Partners & review

  • Industry, universities, nonprofit and government collaborators within eligibility limits

Office links are editorial matches to the original role text, not verified delegations. Composite labels and unmatched actors are preserved.

Coordination pathway

Technical lead → ORTA/counsel → laboratory director/required agency approval → signed CRADA with contribution and IP schedule.

Actor and execution-role sources

October 5 statutory review

Add adjacent duty and confidentiality context without inventing a separate financing or licensing instrument.

Section coverage and review findings

What this research establishes

Legal basisSources linkedLegal sources and instrument limits are recorded.
RequirementsGates recordedRead the requirements for this instrument; applicability depends on the proposed action.
Public fundingRules recordedPartner funds may be accepted, retained and used for collaboration; lab supplies authorized in-kind resources. Office budget figures are separate institutional context, not an allocation to this instrument.
Assigned rolesRoles recordedPublic sources describe institutional authority. The instrument identifies approval and execution roles; a specific signature remains transaction-dependent.
EngagementProcess sourcedTurn a shared laboratory R&D objective into a defined project and negotiated contributions—not a request for federal cash. Program check: 2026-10-04; see each route for intake status.

Confidence: High on express authority and cited conditions; execution assignment is illustrative unless statute expressly names it.

Currentness: GovInfo 2024 Code (includes FY2025 NDAA, P.L. 118-159) read in full for cited provision; targeted FY2026 NDAA P.L. 119-60 amendment/repeal sweep. No claim of complete legislative currency through 2026-10-02; remaining 2026 delta needs counsel validation.

Review scope: Original research target October 2, 2026; no record-specific last-review date supplied. Publication is not legal-currentness certification.